92PDFirst-line afatinib for advanced EGFRm+ NSCLC: Analysis...

Annals of Oncology 2017 / 04 Vol. 28; Iss. suppl_2

92PDFirst-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders (LTRs) in the LUX-Lung (LL) 3, 6 and 7 trials

Schuler, M., Paz-Ares, L., Sequist, L.V., Wu, Y-L., Geater, S.L., Märten, A., Fan, J., Park, K., Yang, J.C-H.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx091.012
Date:
April, 2017
File:
PDF, 52 KB
english, 2017
Conversion to is in progress
Conversion to is failed